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Abstract: The aim of this study was to
evaluate the quanititation of the nuclear size
of tumor cells in superficial bladder
carcinomas in progression and recurrence.

microscopic morphometric analysis. On each
slide the diameters of 800 cells were
measured and the mean nuclear volume of
each was calculated.

Thirty-four cases diagnosed primarily as
superficial bladder carcinoma grade II
without muscle invasion (Stage pTa and pT1)
between 1986-1993 at the Department of
Pathology of Akdeniz University Faculty of
Medicine were analysed in three groups:

3- Twelve cases with superficial primary
tumor and recurrent tumor with muscle
invasion.

In group 1, the mean nuclear volume was
142±9.58 µm3. In group 2 and 3 the mean
nuclear volumes were 207±39.5 µm3 and
3
299±36.5 µm , respectively. Our results
showed that the primary tumors with high
mean nuclear volume had higher rates of
recurrences and muscle invasion than the
primary tumors with low nuclear volumes
and quantitation of nuclear size couldd be
beneficial for follow-up of the recurrence and
progression of grade II superficial bladder
tumors.

The mean nuclear diameter of the tumor cells
were obtained by using simple light

Key Words: Morphometry,
Transitional Cell Carcinoma.

1- Ten cases without recurrent tumor.
2- Twelve cases with primary and recurrent
superficial bladder tumor.

Departments of 1 Pathology 2 Medical Statistics,
Faculty of Medicine, Akdeniz University,
Antalya-Turkey

Introduction
In the urologica practise, one of the most important
problems is the management of patients with superficial
bladder carcinoma (1, 2).
When compared to 30% of patients with tumor
invading lamina propria recurrence with tumors merely
limited to the mucosa occurs in 4% of patients after
transurethral resection (3, 4). Furthermore in superficial
bladder carcinoma (Ta, T1) this conservative treatment
procedure appears insufficient to prevent the
development of the recurrent disease and the progression
to high grade carcinoma which occur in 15% to 25% of
patients or to muscle invasion (5, 6).
Unfortunately, with their unpredictable course and
variable survival rates grade II carcinomas (WHO
Classification) constitute a large heterogenous group (1,
7, 9). In the management of transitional cell carcinomas
of the urinary bladder, the theropeutic approach depends
considerably on the histopathologic grading, but a
completely objective grading system is still unavailable (4,

Bladder,

10). As shown by Ooms et al. (10) the consistency and
reproducibility of the histologic grading by different
pathologists is very low. For these reasons superficial and
low grade tumors need more objective grading criteria
(4, 9-18).
Recently, several authors have shown that
morphometric analysis is a valuable tool for grading
urinary bladder carcinomas as in other organ tumors
(12,14).
In this study using simple light microscopic
morphometric analysis, we compared the mean nuclear
volume of primary tumor cells with tumor progression
and recurrence in cases diagnosed as grade II, stage pTapT1 bladder carcinoma.
Materials & Methods
Selection of cases: In our study we analyzed 34 cases
(mean age 59 years, min 24-max 74 years), which all had
grade II transitional cell carcinoma staged pathologically
as pTa and pT1 between 1986-1993 at the Department
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of Pathology of the Akdeniz University Faculty of
Medicine.
Acording to the 5 year clinical follouw-up the cases
were seperated into 3 groups:
Group 1: Ten cases with no subsequent recurrence at
least 5 years after the diagnosis of the primary tumor.
Group 2: twelve cases with superficial primary tumor
(pTa-pT1) and superficial recurrent tumor (pT1). Group
3: twelve cases with superficial primary tumor (pTa-pT1)
and recurrent tumor with muscle invasion (pT2-pT3).
One case from each group was staged as pTa.
Histological specimens: 4 µm thick H-E stained
sections were cut from the original routinely processed,
paraffin embedded tissue blocks.
Staging and grading: TNM system was used for the
surgical staging, AJCC for the pathological staging and
the grading was performed basically according to the
WHO system (7, 8).
Morphometric analysis: The morphometric analysis
was carried out by a researcher without any knowledge
of which patients the tumors came from and the clinical
outcome.
With a Nikon Optiphot microscope with a 100X oil
immersion lens-the final magnification was 1500-the
slides of each case were examined with a 100 µm
micrometer inserted into the microscope ocular.
On the slides, the areas of necrosis or primary fibrous
tissue were not evaluated.
Ten areas including superficial and basal layers were
selected. In each case the diameters of 800 cells were
measured.
The nuclear diameters were calculated by the square
root of the multiplication of the long and short axis of the
cell nuclei by the measurement of eighty cells in each area.
Cells with pyknotic nuclei, degenerated cells or
superficial cells near the lumen were not seleted for this
study.
After the measurement of the mean nuclear diameters
for each tumor the mean nuclear volume was calculated
with the equatin:
V: Volume
r: Mean radius of the cells

4π x r3
V = ––––––––
3

Statistics: Student’s T test, t test for paired
observation and coefficient of correlation tests were
applied.
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Results
The mean nuclear volume of the tumor cells in the
patients with one primary tumor without subsequent
recurrence for at least 5 years varied from 108 µm3 to
215 µm3 with a mean of 142.5± 9.58 µm3 with one
patient above this value.
In group 2 the mean nuclear volume of tumor cells in
the original bladder tumor varied rom 75 µm3 to 577
µm3 with a mean of 207±39.5 µm3.
Eight of the 12 patients had values above 142.5±
9.58 µm3. In the same group the mean nuclear volume
of the recurrent superficial tumors ranged from 101µm3
to 193 µm3 with a mean of 152±28.42 µm3. In the
group of patient with recurrence leading to invasion, the
mean nuclear volume varied from 94 µm3 to 496 µm3
with a mean of 299±3.65 µm3. Ten of the 12 patients
had values above 142.5±9.58 µm3 .
The mean nuclear volume of the recurrent tumors
with muscle invasion was 386±142.66 µm3 ranging from
155 µm3 to 666 µm3.
There was no evident difference between the mean
nuclear volumes of group 1 and group 2 patients
(p>0.05). However the differences between group 1 and
group 2 and group 3 were statistically significant
(p<0.05) (Figure 1).
The primary and recurrent values of group 1 and
group 2 were similar with a low variation of distribution.
However a higher value and variation were found in
group 3. While the coefficient of correlation of the
primary and recurrent values of group 2 was r= 0.34 the
value of group 3 was r= 0.80 (p<0.05).
Discussion
Factors influencing recurrence and progression of
superficial bladder cancer have been investigated many
times and conflicting results reported in several papers
19,24 The proliferation index of Ki-67 and PCNA,
overexpression of p53, bcl-2, c-myc oncogenes and the
presence or absence of growth factor receptors on tumor
cells were evaluated (19, 20, 21, 23, 24).
However at present we are not able to identify
accurately which patient with superficial bladder
carcinoma is at increased risk of the invasive disease.
On the other hand, there is increasing evidence
demonstrating the value of nuclear morphometry and
recently a number of reports considered cell and nuclear
size, nuclear areas and cell areas as a marker of tumor
behavior (15,18). The detection of tumor progression
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Figure 1.

Distribution of mean nuclear
volume of primary and
recurrent tumors for three
groups. Prim: primary
tumor, Rec: recurrent
tumor. Prim1: Ten patients
with only one tumor. Prim
2, Rec 2: Twelve patients
with recurrent noninvasive
tumor. Prim 3, Rec3:
Twelve patients with bladder
tumor leading to invasion.

Figure 2.

The mean nuclear volume of
tumor cells in three groups
of patients. Prim: Primary
tumor, Rec: Recurrent
tumor. Prim 1: Group 1,
Prim 2, Rec 2: Group 2,
Prim 3, Rec 3: Group 3.
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and recurrence morphometric parameters has also been
applied in the field of bladder carcinoma, but the results
remain controversial (4, 10, 25-29).

volume of the primary tumor cells was significantly larger
than the other two groups and this value was the greatest
in their reccurences.

Colombel et al (26) reported that morphonuclear
parameters correlated well with tumor progression and
recurrence in bladder carcinoma. Borland pointed out that
nuclear morphometry could be useful in the detection of
recurrence in deeply invasive tumors (26) . In contrast
Vale did not observe any predictive no additional
prognostic information in superficial bladder carcinoma
(27).

In our cases, while 10 of the 19 primary tumors with
a mean nuclear volume above the 142.5±9.58 µm3
distribution value had subsequent musle invasion.

In our study, in group 3 patients there was a 55 µm3
increase in the mean nuclear volume of recurrent tumor
values compared with the primary tumor (Figure 2). For
the primary tumors of this group, the mean nuclear

This finding supported the concept that the mean
nuclear volume of the primary superficial grade II tumor
cells in the great majority of cases ending with recurrent
muscle invasion was larger than the cases with no
recurrence or superficial recurrence. Although there are
numerical variations when compared with the study by
Nielsen et al (4, 10), our results had similar mean nuclear
volume relations.
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Our results showed that in the group of patients with
no recurrence the mean nuclear volume of the primary
tumor was significantly lower than the primary tumors of
the patients who had recurrence. However, this difference
was not statistically significant.
In group 2 patients there was an 86.2 µm3 decrease
in the mean nuclear volume of the recurrent tumor values
compared with the primary tumors. In other words there
was an inverse correlation betwween the primary and
recurrent tumors of this group. The difference between
the mean nuclear volume of the recurrent tumor cells of
group 2 and primary tumor cells in group 1 was also very
low (9.5±18.84 µm). The decrease in the mean nuclear
volume of the recurrent tumor cells in superficially
recurrent tumor compared with their primary and the
close proximity of this value to the mean nuclear volume
of the tumor cells of the group 1 remains to be explained.
Perhaps the metabolic status of the nucleus of the tumor
cells with no recurrence or superficially recurrence
potential could be similar. However we could not agree
with the above findings and think that this subject needs
further investigation concerning molecular basis. To our
knowledge, there is no report concerning this finding at
present. The mean nuclear volume of the primary tumor
of group 2 patients was slightly larger than the primary
tumor with no recurrence, but lower than the primary
tumor of the group 3 patients ending up with muscle
invasion and this difference was statistically significant
(p<0.05).
It is obvious that all tumors diagnosed as grade II
superficial bladder carcinomas by using histopatologic

criteria, form a large heterogeneous group with different
behavior during their follow-up. While some of these
tumors do not recur others recur and also progress.
The aim of our study was to evaluate the accuracy of
the mean nuclear volume of the primary tumor cells in
grade II superficial bladder carcinomas (pTa-pT1) in the
progression and recurrence during the follow-up.
Our results showed that the mean nuclear volume of
the primary tumor cells could be valuable in the detection
of invasive behavior of tumor cells and their recurrence.
In our study we obtained the mean nuclear volume of
the tumor cells after the measurement of the mean
nuclear diameters with an ocular micrometer. This
method is more time-consuming and semi biased when
compared with highly sensitive image analysis systems
and stereology, but is more objective for detecting
recurrence than simple morphological grading (4,13,15).
In addition the methods mentioned above are
expensive and require technical equipments not easily
available everywhere. However we do not suggest that
our method can be used instead of computerized image
analysis and the other systems, but can be a supportive
method to simple morphological grading.
As a conclusion, the mean nuclear volume of tumor
cells is a useful determinant for predicting the future
behavior of grade II, pTa-pT1 transitional cell carcinomas
of the bladder, even with our simple method.
In the future, a standart for measurement will be
carried out and a better comparaison of bladeler tumor
materials will be possible.

References
1.

2.

132

Cabin B-E, Ekman P, Gustafson H,
Christiensen NJ, silfversward C,
Sandstedt B. Grading of human
urothelial carcinoma based on muclear
atypia and mitotic frequency prognostic
importance. J Urol 145: 972-76,
1991.
Parmar MKB, Fredman LS, Hargreave
TB, Tolley DA. Prognostic factors for
recurrence and follow-up policies in the
treatment of superfcial bladder cacer,
Report from the British Medicaal
Research Council subgroup on
superficial bladder cancer J Urol 142:
284-88, 1989.

3.

4.

5.

Heney
NM,
Ahmed
S,
FlanaganJM.Frabe W, Corder MP,
Hafermann
MD,
Hawkins
IR,
Superficial bladder cancer progression
and recurrence: J Urol 130: 1083-86,
1983.
Nielsen K, Colstrup H, Nilsson T,
Stereologic estimates of nuclear
volume in non-invsive bladder tumors
(Ta) correlated with the recurrence
pattern. Cancer 64: 2269-74, 1989.
Barnes R, Hadley H, Dick A, Changes
in grade and stage of recurrent bladder
tumours. J Urol 118: 177-78, 1977.

6.

Melicow M M. Tumors of the urinary
bladder; a clinicopathological analysis
of over 2500 specimens and biopsies.
J Urol 74: 498-503, 1955.

7.

Bearhs OH, Myers MH. Bladder.
Manual For Staging Of Cancer (Eds
Bearhs OH and Myers MH) JB
Lippincott, Philadelphia 1983, pp:
175.

8.

World
Health
Organization,
Histological typing of urinary bladder
tumours: International histological
classification of tumours. Geneva. Wold
Health Organization, 1973.

G. Ö. ELPEK, T. GELEN, G. KARPUZOĞLU, O. SAKA

9.

Blomjous CE, Vos W, Schipper NW,
Uyterlinde AM, Baak JP, de Voogt-HJ
Prognostic significance of selective
nuclear morphometry in urinary
bladder carcinoma. Hum Pathol 21:
409-13, 1990.

10.

Ooms ECM, Kurve PHJ, Veldhuizen
RW,
Alons
CL,
Boon
ME:
Morphometric grading of bladder
tumors in comparison with histological
grading by patholgists. Hum. Pathol
14: 144-50, 1983.

11.

12.

13.

14.

Ooms ECM, Anderson WAD, Alons CL,
Boon ME, Veldhuizen RW. Analysis of
the performance of pathologists in the
grading of bladder tumors. Hum Pathol
14: 140-3, 1983.
Hellander K, Hofer PA, Holmberg G.
Karyometric investigation on urinary
bladder cacinoma correlated to
histopathological gradig. Virchows
Arch A Pathol Anat Histopathol 403:
117-125, 1984.
Nielsen K, Torben O, Wolf H.
Stereologic estimates of nuclear
volume
correlated
with
histopathological
grading
and
prognosis of bladder tumors. Virchows
Arch B Cell Pathol Vol 52: 41-541986.
Sorensen FB. Biology of Disease.
Quantitative analysis of nuclear size for
objective malignancy grading: a review
with emphasis on new, unbiased
stereologic methods. Lab Invest 66:
4,93, 1992.

15.

Fulker MJ, Adamthwait SJ, Anderson
CK. Stereological measurements of
bladder tumours morphology Eur J
Cancer 12: 575-79, 1976.

16.

Goudarzi HAL, Lyttle JA, Mundy AR.
Tumor morphometry as prognostic
factor in T1 and T2 bladder cancer.
Urology 23: 205-7, 1984.

17.

Herder A, Bjelkenkrantz A, Gröntoft O.
Histopathological subgrouping of the
urothelial
neoplasms
by
cotophotometric measurements of
nuclear atypia. Acta Pathol Microbiol
Immunol Scand (Sect A) 90: 405-408,
1982.

23.

Sauter G, Carrol P, Moch H, Kallioniemi
A, Kerschmann R, Narayan P,
Mithatsch MJ, Waldman FM. C-myc
copy number gains in bladder cancer
detected by fluorescence in situ
hybridization. Am J Pathol 146: 11311139, 1995.

18.

Sasaki M, Sorensen FB, Fuzukawa S,
Yamabe H, Olsen S, Yoshida O.
Quantitative histopathology in the
prognostic evaluation of patients with
transitional cell carcinoma of the
urinary bladder. Cancer: 72: 2470-83,
1993.

24.

Shiina H, Igawa M, Yagi H, Urakami S,
Yoneda T, Shirakawa H, Ishibe T.
Immunohistochemistry of p53 protein
in transitional-cell carcinoma of the
bladder using an image anlyzer.
Oncology 53: 233-240, 1996.

25.

19.

Asakura T, Takano y, Iki M, Suwa y,
Noguchi S, Kubota Y, Masuda M.
Prognostic value of Ki-67 for
recurrence and progression of
superficial bladder cance. J Urol: 158:
385-388, 1997.

Colombel M. Prognostic evaluation of
mophonuclear parameters in superficial
and invasive bladder cancer. Br J Urol
75: 364-369, 1995.

26.

Borland RN. The use of nuclear
morphometry in predicting recurrence
of transitional cell carcinoma. J Urol
149: 272-275, 1993.

27.

Vale JA, A’Hern RP, Liu K, Hendry WF,
Whitfield HN, Plowman PN, Sowter c,
Slavin G. Predicting the outcome of
radical radiotherapy for invasive
bladder cancer. Eur J Urol 24: 48-51,
1993.

28.

Lipponen PK. Stereologically measured
nuclear volume in comparaison to
twodimensional nuclear morphometry,
mitotic index and flow cytometry in
predicting disease outcome in bladder
cancer. Anticancer Res 13: 529-532,
1993.

29.

Lipponen PK. The prognostic value of
basement membrane morphology,
tumour histology and morphometry in
superficial bladder cance. J Cancer Res
Clin Oncol 119: 295-300, 1993.

20.

21.

22.

Inagaki T, Ebusino S, Uekado Y, Hirano
A, Hiroi A, Shinka T, Ohkawa T, PCNA
and p53 protein in urinary bladder
cancer: Correlation with histolgical
findigs and prognosis. Int J Urol 4:
172-177, 1997.
King ED, Matteson J, Jacobs SC,
Kyprianou N, Incidence of apoptosis,
cell proliferation and bcl-2 expression
in transitional cell carcinoma of the
bladder: association with tumor
progression. J Urol 155: 316-320,
1996.
Lacombe L, Gauthier J, Lafleur L,
Fradet Y, Clinical volue of the study of
proliferation and cell activation antgens
with flow cytometry in bladder cancer.
Prog Urol 6: 907-912, 1996.

133

